tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HALO Stock Latest News

Halozyme price target raised to $94 from $78 at Morgan Stanley
The FlyHalozyme price target raised to $94 from $78 at Morgan Stanley
7d ago
HALO
Halozyme price target raised to $90 from $75 at Benchmark
PremiumThe Fly
Halozyme price target raised to $90 from $75 at Benchmark
7d ago
HALO
Halozyme price target raised to $75 from $65 at Wells Fargo
PremiumThe Fly
Halozyme price target raised to $75 from $65 at Wells Fargo
7d ago
HALO
Halozyme Earnings Call Highlights Royalty-Fueled Growth
PremiumCompany Announcements
Halozyme Earnings Call Highlights Royalty-Fueled Growth
7d ago
HALO
Halozyme: Strong Royalty Momentum and Underappreciated Multi‑Year Earnings Power Support Buy Rating
PremiumRatings
Halozyme: Strong Royalty Momentum and Underappreciated Multi‑Year Earnings Power Support Buy Rating
8d ago
HALO
Halozyme reaffirms FY26 non-GAAP EPS view $7.75-$8.25, consensus $8.18
PremiumThe FlyHalozyme reaffirms FY26 non-GAAP EPS view $7.75-$8.25, consensus $8.18
8d ago
HALO
Halozyme reports Q4 EPS 24c vs. $1.26 last year
Premium
The Fly
Halozyme reports Q4 EPS 24c vs. $1.26 last year
8d ago
HALO
Genmab sees 2026 revenue $4.065B-$4.395B, consensus $4.13B
Premium
The Fly
Genmab sees 2026 revenue $4.065B-$4.395B, consensus $4.13B
8d ago
JNJ
GMAB
HALO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
HALO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
11d ago
HALO
Halozyme sees FY26 EPS $7.75-$8.25, consensus $8.21
PremiumThe Fly
Halozyme sees FY26 EPS $7.75-$8.25, consensus $8.21
29d ago
HALO
Halozyme raises FY25 revenue view to $1.39B-$1.4B from $1.3B-$1.38B
PremiumThe Fly
Halozyme raises FY25 revenue view to $1.39B-$1.4B from $1.3B-$1.38B
29d ago
HALO
Leerink views ‘major deal’ on Entyvio as positive for Halozyme
PremiumThe Fly
Leerink views ‘major deal’ on Entyvio as positive for Halozyme
2M ago
TAK
HALO
Halozyme: ENHANZE Platform Partnerships in Immunology and Obesity Drive Underappreciated Royalty Upside and Support Buy Rating
PremiumRatingsHalozyme: ENHANZE Platform Partnerships in Immunology and Obesity Drive Underappreciated Royalty Upside and Support Buy Rating
2M ago
HALO
Halozyme price target raised to $90 from $79 at TD Cowen
Premium
The Fly
Halozyme price target raised to $90 from $79 at TD Cowen
2M ago
HALO
Halozyme announces global collaboration, license agreement with Takeda
Premium
The Fly
Halozyme announces global collaboration, license agreement with Takeda
2M ago
TAK
HALO
Halozyme price target lowered to $75 from $79 at Morgan Stanley
PremiumThe Fly
Halozyme price target lowered to $75 from $79 at Morgan Stanley
2M ago
HALO
CoreWeave initiated, Shopify downgraded: Wall Street’s top analyst calls
PremiumThe Fly
CoreWeave initiated, Shopify downgraded: Wall Street’s top analyst calls
2M ago
ACN
CVX
Skye Bioscience, Halozyme enter collaboration, license agreement
PremiumThe Fly
Skye Bioscience, Halozyme enter collaboration, license agreement
2M ago
HALO
SKYE
Halozyme, Skye Bioscience announce global collaboration, license agreement
PremiumThe Fly
Halozyme, Skye Bioscience announce global collaboration, license agreement
2M ago
HALO
SKYE
Rybrevant FASPRO Approval and ENHANZE Royalties Reset Halozyme’s Long-Term Growth Outlook, Supporting a Buy Rating and $90 Target
PremiumRatingsRybrevant FASPRO Approval and ENHANZE Royalties Reset Halozyme’s Long-Term Growth Outlook, Supporting a Buy Rating and $90 Target
2M ago
HALO
Johnson and Johnson’s Rybrevant Faspro combination in NSCLC approved by FDA
Premium
The Fly
Johnson and Johnson’s Rybrevant Faspro combination in NSCLC approved by FDA
2M ago
JNJ
HALO
Halozyme Approves Stock Grant for CEO Incentive
Premium
Company Announcements
Halozyme Approves Stock Grant for CEO Incentive
3M ago
8K
HALO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >